Home » Research Area » » Ion Channels » Ligand-gated Ion Channels » Glutamate (Ionotropic) Receptors » NMDA Receptors » (S)-(+)-Ketamine hydrochloride

(S)-(+)-Ketamine hydrochloride

Cat. No. 4379

Price and Availability

For (S)-(+)-Ketamine hydrochloride pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: (S)-(+)-2-(2-Chlorophenyl)-2-(methylamino)cyclohexanone hydrochloride

Biological Activity

NMDA receptor antagonist. Displays neuroprotective efficacy in vitro. Racemate (Cat. No. 3131) also available.

Technical Data

M.Wt:

274.19

Formula:

C₁₃H₁₆ClNO.HCl

Solubility:

Soluble to 100 mM in water

Purity:

>99 %

Storage:

Store at RT

CAS No:

33643-47-9

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Other Information

Racemate Available

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch

Safety Data Sheet: View Safety Data Sheet

References

Ryder et al (1978) Comparative pharmacology of the optical isomers of ketamine in mice. Eur.J.Pharmacol. 49 15. PMID: 658124.

Proescholdt et al (2001) Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Res. 904 245. PMID: 11406122.

Benrath et al (2005) Low dose of S(+)-ketamine prevents long-term potentiation in pain pathways under strong opioid analgesia in the rat spinal cord in vivo. Br.J.Anaesth. 95 518. PMID: 16113037.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Glutamate (Ionotropic) Receptors

NMDA Receptors

Keywords: (S)-(+)-Ketamine hydrochloride, supplier, nmda, nmdar, antagonists

Quick Order

Find multiple products by catalog number

Pain Research Guide

Reserve your free copy

Highlights over 280 products for Pain research. Reserve copy

Therapeutic Strategies in Schizophrenia

Written by J. Lieberman

'Schizophrenia - Emerging Targets and Therapeutic Strategies' provides a summary of the targets and pathways representing the most promising strategies to pursue for novel drug development.

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

Neurobiology of Parkinson's Disease

Written by A. Schapira

'Neurobiology and Therapeutics of Parkinson's Disease' highlights the neurobiology of Parkinson's disease and summarizes current and novel therapeutic interventions.